59
Instructions for use Title 荷電粒子入射反応における医療用放射性核種169Ybの生成断面積測定 Author(s) 花田, 萌美 Citation 北海道大学. 博士(医理工学) 甲第14118号 Issue Date 2020-03-25 DOI 10.14943/doctoral.k14118 Doc URL http://hdl.handle.net/2115/78121 Type theses (doctoral) File Information Moemi_Hanada.pdf Hokkaido University Collection of Scholarly and Academic Papers : HUSCAP

荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

Instructions for use

Title 荷電粒子入射反応における医療用放射性核種169Ybの生成断面積測定

Author(s) 花田, 萌美

Citation 北海道大学. 博士(医理工学) 甲第14118号

Issue Date 2020-03-25

DOI 10.14943/doctoral.k14118

Doc URL http://hdl.handle.net/2115/78121

Type theses (doctoral)

File Information Moemi_Hanada.pdf

Hokkaido University Collection of Scholarly and Academic Papers : HUSCAP

Page 2: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

1

169Yb

(Cross section measurements of charged-particle induced reactions

to produce medical radionuclide 169Yb)

2020 3

(Moemi HANADA)

Page 3: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150
Page 4: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

169Yb

(Cross section measurements of charged-particle induced reactions

to produce medical radionuclide 169Yb)

2020 3

(Moemi HANADA)

Page 5: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

、 ...................................................................................................................1

1. ............................................................................................................................................................................2

1.1 n .................................................................................................................................................. 2

1.2 n .......................................................................................................................... 3

1.3 -169L169YbM ...................................................................................................................................... 4

1.4 169Yb ................................................................................................................................................................ 5

1.4.1 169Tm ................................................................................................................................................................ 6

1.4.2 169Tm ........................................................................................................................................................... 7

1.4.3 169Tm ............................................................................................................................................. 8

1.4.4 natEr ............................................................................................................................................. 10

1.5 ................................................................................................................................................................... 11

........................................................................................................................................................................ 12

2. ............................................................................................................................................................... 13

2.1 Lactivation methodM .................................................................................................................................. 13

2.2 Lstacked foil methodM ............................................................................................................................... 13

2.3 Lgamma-ray spectrometryM....................................................................................................... 14

2.4 ................................................................................................................................................................................. 15

2.5 ................................................................................................................................................................... 16

3. ............................................................................................................................................................... 17

3.1 169Tm .................................................................................................................. 18

3.1.1 ...................................................................................................................................................................................................... 18

3.1.2 .................................................................................................................................................................................. 19

3.1.3 ............................................................................................................................................................................................ 20

3.1.4 ............................................................................................................................................................................................ 21

3.2 natEr ..................................................................................................................... 22

3.2.1 ...................................................................................................................................................................................................... 22

3.2.2 .................................................................................................................................................................................. 24

3.2.3 ............................................................................................................................................................................................ 24

3.2.4 ............................................................................................................................................................................................ 25

4. ............................................................................................................................................................... 26

4.1 169Tm .................................................................................................................. 26

Page 6: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

4.1.1 169Yb ............................................................................................................................................................................................ 28

4.1.2 169Yb ....................................................................................................................................................................................... 29

4.1.3 .............................................................................................................................................................................. 30

4.2 natEr ..................................................................................................................... 37

4.2.1 169Yb ............................................................................................................................................................................................ 39

4.2.2 169Yb ................................................................................................................................................................................... 40

4.2.3 .............................................................................................................................................................................. 41

5. ......................................................................................................................................................................... 48

6. 、 ................................................................................................................................................. 49

............................................................................................................................................................................. 50

................................................................................................................................................................... 51

Page 7: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

1

t 、 H

1. M. Saito, M. Aikawa, H. Haba, Y. Komori, S. Takács Production cross sections of 169Yb and Tm isotopes in deuteron-induced reactions on 169Tm Applied Radiation and Isotopes 125, 23-26, 2017

2. M. Saito, M. Aikawa, M. Sakaguchi, N. Ukon, H. Haba, Y. Komori, S. Takács Production cross sections of ytterbium and thulium radioisotopes in alpha-induced nuclear reactions on natural erbium Applied Radiation and Isotopes 154, 108874, 2019

t H

a. ・ Sandor Takacs 169Tm 169Yb

2016 , 2016 9 7 ~9 I b. ・

169Yb natEr 50 MeV

2019 , 2019 3 20 ~22 I

c. ・ Sandor Takacs 169Yb

2019 , 2019 9 11 ~13 I I

Page 8: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

2

1.

1.1 n

t n b YH t mQ

mt Y H aH

-131L131IM

8.02 mQ H Vm H a nV

H

-125L125IM

59.4 I mQ HV H

n H

-192L192IrM

73.8 I mQ HV H

-99mL99mTcM

6 mQ H L mt 140 keVM an LSingle photon emission computed

tomography, SPECTM H a t mQ 99MoLT1/2 = 66M n m 99mTc H m

8 T H

-18L18FM

110 mQ H n n 511 keV a n LPositron emission tomography, PETM H b

n H

t am n mH H

VH

Page 9: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

3

t 100 T n (U.S. Department of Energy)H

1.2 n

ta Q H a n a

mQ Lcross sectionM Q H V g tt H a mmQ Q Q n

H a a n t m

Lthick target yield, TTYM H V mQ t (Otuka and Sándor Takács, 2015) a H

m a t a Q H Q H mt

a n m 99mTc mQ 99MoH V m

H n [ (Van Noorden, 2013) Y Y

Yt HV H T n

99Mo/99mTc t 15 n (Van Noorden, 2013)H

t T H VH

m t nH

nt anmQ H mt nt

n mQ Hn m H

t t n -169L169YbMa H

Page 10: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

4

1.3 -169L169YbM

169Ybt 32.02 m 49.8 keVV 307.7 keV L 93 keVM amQ H mQnV 125I 192Ir a n mQ n T (Lymperopoulou et

al., 2006)H e 1 aHa n e ]n

n m H 1 169Ybn 125I 192Ir

169Yb 32.0 g 49.8 - 308.7 keV 93 keV 168Yb(n,g)169Yb

125I 59.4 g 35.5 keV (g), 27.5 keV 31.0 keV ( X )

28.5 keV 124Xe(n,g)125Xe 125I

192Ir 73.8 b g 130 - 1060 keV (b), 256 - 672 keV (g)

350 keV 191Ir(n,g)192Ir

177.21 keVLIg = 22.16%Mn 197.96 keVLIg = 35.8%M

nV 169Yb L169Yb-DTPAM m(DeLand et al., 1971)H

Page 11: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

5

1.4 169Yb

1-1 169Yb aH

.((-,5 (--5 (-.5 (- 5 (-05 (. 5 (.(5 (.)5 (. 5

.(-+ (-, (-- (-. (-

()

(-0 (.

) 0 )

(.(

)(-

(.)

(-(

-0(-8

(-+8

(-,8

(--8

(-.8

(-8

(-08(

(.8

(.(8

-(-)2( 0

(-2

(-+2

(- (

(-,2

(--2,

(-.2

)) -0

(-2

)-0.

(-02

(.2

(+0( 0+ 0, 0- 0. 0 00 ( ( ( ( )

(%( (-0

t H

169Yb t 168YbH V 168Ybt 0.123%n Y 169Yb

t n H mt VmQ t n H

169Yb t 2 Q[ T H me a H

t LInternational Atomic Energy Agency; IAEAM a EXFOR(Otuka et al., 2014)

H 2 169Yb a [ ] [MeV]

169Tm(p,n)169Yb 4 4-50 169Tm(d,2n)169Yb 3 4-50 169Tm(a,tn)169Yb 1 43-66 169Tm(a,4n)169Lu 169Yb 5 37-65 natEr(a,x)169Yb 4 10-84 166Er(a,n)169Yb 2 11-17 167Er(a,2n)169Yb 0 - 168Er(a,3n)169Yb 0 - 170Er(a,5n)169Yb 0 -

e nn 、 kY LTENDL-2017M(Koning et al., 2019) 1.4.1 V 1.4.4 H

Page 12: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

6

1.4.1 169Tm 4 (Birattari et al., 1973; Spahn et al., 2005; Sonnabend et al., 2011; Tárkányi et al., 2012)

a 1-2 Hn a nm

V m V a 、H V V mt 2 (Birattari et al., 1973; Spahn et al., 2005)

Q t 2 Q mQ HTENDL-2017(Koning et al., 2019)t 8 MeV mt n a

t Y 15 MeV tH ]n b t e

mQ n T H

1-2 169Tm 169Yb H n TENDL-

2017

0

50

100

150

200

250

300

350

0 10 20 30 40 50

169Tm(p,n)169Yb

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Birattari 1973Spahn 2005Sonnabend 2011Tarkayni 2012TENDL-2017

Page 13: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

7

1.4.2 169Tm L2016 (Saito et al., 2017)M

m t 3 (Tárkányi et al., 2007; Hermanne et al., 2009, 2016)mQ H t m LTm2O3M

n tt mQ n H V V n T

u n V H m mtmQ n T H

1-3t 3 n 、 TENDL-2017(Koning et al., 2019)n mQ H t n a

t n HTENDL-2017 tY H

1-3 169Tm 169Yb H n TENDL-

2017

0

100

200

300

400

500

600

700

800

0 10 20 30 40 50

169Tm(d,2n)169Yb

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Tarkanyi 2007Hermanne 2009Hermanne 2016TENDL2017Saito 2017

Page 14: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

8

1.4.3 169Tm t 7 (Sau, Demeyer and Chéry, 1968; Leyden and Murthy, 1988; Singh, Agarwal and Rama

Rao, 1990; Mohan Rao, Mukherjee and Rao, 1992; Mohan Rao and Chintalapudi, 1994; Kiss et al., 2011; Rauscher et al., 2012)Q H V

mQ Lu 169Yb t 1mQ H 169Yb Yt

mQ mQ H 1-4 169Yb n 、 mQ TENDL-2017naH

1-4 169Tm 169Yb H n

TENDL-2017

mt 169Yb mQ 169LuLT1/2 = 34.06 M H 1-5169Lu n TENDL-2017n aH5 m

t n H n TENDL-2017t mQ H

0

50

100

150

200

30 35 40 45 50 55 60 65 70

169Tm(α,x)169Yb

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Mohan Rao 1992TENDL-2017

Page 15: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

9

1-5 169Tm 169Lu H n

TENDL-2017

0

200

400

600

800

1000

1200

1400

30 35 40 45 50 55 60 65 70

169Tm(α,4n)169Lu

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Sau 1968Singh 1990Mohan Rao 1992Mohan Rao 1994Patel 1999TENDL-2017

Page 16: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

10

1.4.4 natEr t 4 (Homma et al., 1980; Archenti et al., 1985; Mohan Rao, Mukherjee and Rao, 1992;

Sonzogni et al., 1992; Király et al., 2008; Kiss et al., 2015) a 1-6 a mY a V m H n

m b a n YmQ n T H

1-6 natEr 169Yb H n

TENDL-2017

0

100

200

300

400

500

600

0 10 20 30 40 50 60 70 80 90

natEr(α,x)169Yb

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Homma 1980Sonzogni 1992Archenti 1985Kiraly 2008TENDL2017

Page 17: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

11

1.5

V 169Yb a t g mQ nV H 169Yb

a nm H 169Ybm a n m na H

mt 169Yb n mQ H mQ 169Tm

(Saito et al., 2017) T 169Tm natErH 169Yb Y

a n m H

Page 18: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

12

m t mQ HL M AVF azimuthally varying field PET positron emission tomography SPECT single photon emission computed tomography

Page 19: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

13

2.

m n3 [ H mt 3 n a

a H

2.1 Lactivation methodM

a n aa nm a mQ H

mt aH e t a

a n mQ H t H

! = #$%&'&$&()()*(1 − ./0(1)./0(3(1 − ./0(4)

Tγ Nt QNb εd εγ εt

λ tb tc tmn H

2.2 Lstacked foil methodM

n r n ma mQ H t m

Y n H t n na r a H

mt e t SRIM(Ziegler, Biersack and Ziegler, 2008) nm t LTime of flightM(Watanabe et al., 2014) H

r 2-1 a Y t Ha n n n

H a n H m a2-1 n a n

r 2 a nm n a nm H r n t nt Y

n a nmt n H V

Page 20: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

14

V n Y Vn n H

2-1

2.3 Lgamma-ray spectrometryM

aa nm H et a (Chu, Ekström and

Firestone, 1999; International Atomic Energy Agency, 2009; National Nuclear Data Center, 2017)a H

t mQ LSEIKO EG&GMH ]n a

L 2-2MH m a nmn n H

Page 21: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

15

2-2

2.4

t RI Q LHyper-pure Germanium, HPGeM H n r m

H 3 m n H 3

det. 1 GMX-25190-P ORTEC Tm+a 1 det. 2 GMX30P4-70 ORTEC Tm+a 2, Er+a det. 3 GEM30P4-70 ORTEC Tm+a 2, Er+a

e t 57,60Co, 88Y, 109Cd, 113Sn, 137Cs, 139Ce 241AmV LEckert

& Ziegler Isotope Products Inc.M H

Page 22: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

16

2-3

2.5

LIAEAMmta Y V (Hermanne et al., 2018)

H 27Al, natTi, natCu n Va u HIAEAmt a

H n en a nm m n T H

mt n a nmH t IAEA (IAEA -

Nuclear Data Section)V mQ H

Page 23: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

17

3.

t RI AVF Ht mQ m Y Q H

mQ 50 MeV mH

3-1 L Mn AVF L M

e 4 aH + (-08 E2

(-08 #a ()

) (. . ,(-6 9 (. - 1 )) (0 ) , .6 9 ( - 1 (

E2 #a ) ( 0 , 06 9 ) 1 (4 t mQ H t

m a n m H Va n m H

Page 24: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

18

3.1 169Tm

169Tm t 2017 n Yn 2019 2 H

3.1.1 169Tm t 169Tm 1 27Al 2 1n 9 r 27 m H2019 mt 2017 n

T 27Al 1 28 n H tn 30 MeV a n H t 3-2L M

a 99.0% 169Tm L28.65 mg/cm2, Goodfellow Co., Ltd., UKMn 99.6%27Al L1.50 mg/cm2, Nilaco, Corp., JapanM H169Tm 27Al et n a nm H 169Tm t 2016

2 m 2017 2019 2H t ]n H 3-2

25 mm 169Tm n 8 mm 169Tm 27Al aHt 3-1m H

3-2 25 mm 169Tm L Mn 8 mm 169Tm 27Al L M

Page 25: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

19

3.1.2 a

V IAEA n 3-3 aHt m

mQ H m t 30 MeV m27Al(a,x)22Na n H

3-3 169Tm 27Al(a,x)22Na

t 22NaLT1/2 = 2.6027 M 1274.53 keVLIγ = 99.944%M a nm H

1t 3 0.3% m HV V 10% a IAEA n H

u V tm Y n T mQ H

2t 2 m e IAEA n Yt V H e

t mQ H Det2; 6 0.05% H Det3; 1 0.4% H

t Y Ht m g Hn H

0

10

20

30

40

50

60

30 35 40 45 50 55

27Al(α,x)22Na

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Recommended valueThis work #1 (det 1)This work #2 (det 2)This work #2 (det 3)

Page 26: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

20

3.1.3 169Tm 50 MeV e

LQ M 5 aH a tNuDat 2.7(National Nuclear Data Center, 2017) Lund/LBNL Nuclear Data Search(Chu, Ekström and Firestone, 1999) Live Chart(International Atomic Energy Agency, 2009)V Q tQCalc(Pritychenko and Sonzogni, 2003)V H

, (-08 7

2g A 9 4g 7

6 9(.) 5 -. e ( . .+)- ( - a %( )

( (,) ) - +( -+ (-- ),0 .)+ )0 +0()(), (,), ),( 0 -,. -), (

(.( 5 )+ e ( (0 0+ ( . . a ) %(.)--.+ + (( +. 0. +. .

(. 5 ) () e ( +), 0 , a %),(0 ( )(+ .() ), ( )

(-05 + - e ( (0()( . ) - , a + % (

0- -)) ) + ,(++0.+ 00) )(

(-.8 0), e(100) ) . +( - aa) %(+0 (-. e

(- 8 0 ( e 0000b% (

aa %

(. 8 () - e 00 .b% (

+ ), ), a 3 %(+

(-. (. , e ( % % a E % . +(-0 ) ( e ( - () ++) - a E %)( ,

( 0. (.+. ( (-05 e( ,) (( ( 0(..)( ))(- ((0.0- ,

Page 27: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

21

3.1.4 1m t 12.3-54.9% n H t L0.3-49.7%ML2%M L1%M L10%M L6%M

L< 6%M L3%M V 2 。 mH 2m t 8.7-44.6% n H t L0.1-43.8%ML2%M L1%M L5%M L6%M

L< 6%M L3%M V 2 。 mH

Page 28: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

22

3.2 natEr

3.2.1 n LnatErM t 6 a mQ H

6 natEr 162Er 164Er 166Er 167Er 168Er 170Er

0.139% 1.601% 33.503% 22.869% 26.978% 14.910% VV t

H natEr mt Y

7 32 V H t 3-4L M a99% natEr L20.06 mg/cm2, Goodfellow Co., Ltd., UKMn 99.6% natTi L2.26 mg/cm2, Nilaco Corp., Japan) HnatEr natTi t

a nm H 3-4 50 mm natEr n 8 mmnatEr natTi aH t 3.1.1 n

H 7 natErn natTi

1 Er 17 Ti 2 Er 18 Ti 3 Er 19 Er 4 Er 20 Er 5 Ti 21 Er 6 Ti 22 Ti 7 Er 23 Ti 8 Er 24 Er 9 Er 25 Ti 10 Er 26 Ti 11 Ti 27 Er 12 Ti 28 Ti 13 Er 29 Ti 14 Er 30 Er 15 Er 31 Ti 16 Er 32 Ti

Page 29: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

23

3-4 50 mm natEr L Mn 8 mm natEr natTi L M

Page 30: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

24

3.2.2 169Tm a

IAEA n 3-5 aH mt 16-50 MeV m a n m natTi(a,x)51Cr n H

3-5 natEr natTi(α,x)51Cr

t 51Cr (T1/2 = 27.7025 ) 320.08 keV (Iγ = 9.910%) a nm H12 1.1% m

HnatEr m L-1%Ma n IAEA nH m n 2% mQ n n [ H

H

3.2.3 natEr 50 MeV eQ 8 aH a t NuDat 2.7(National Nuclear Data Center, 2017)

Lund/LBNL Nuclear Data Search(Chu, Ekström and Firestone, 1999) Live Chart(International Atomic Energy Agency, 2009)V Q tQCalc(Pritychenko and Sonzogni, 2003)V H

0

100

200

300

400

500

600

700

0 10 20 30 40 50

natTi(α,x)51Cr

Cro

ss s

ectio

n (m

b)

Energy (MeV)

RecommendedThis work

Page 31: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

25

8 natEr 7

[%] Eg [keV] Ig [%] Q

[MeV] 169gYb 32.02 e (100) 63.12044(3) 43.62(23) 166Er(a,n)169Yb -10.2 177.21307(4) 22.28(11) 167Er(a,2n)169Yb -16.6 197.95675(4) 35.93 168Er(a,3n)169Yb -24.4 170Er(a,5n)169Yb -37.7 166Yb 56.7 e (100) 82.29(2) 15.552 162Er(a,g)166Yb -2.3 164Er(a,2n)166Yb -18.1 166Er(a,4n)166Yb -33.2 167Er(a,5n)166Yb -39.6 168Er(a,6n)166Yb -47.4 173Tm 8.24 b-(100) 398.9(6) 87.9(9) 170Er(a,p)173Tm -8.7 170Tm 128.6 b-(99.87) 84.25474(8) 2.48(6) 167Er(a,d)170Tm -8.4 e (0.13) 168Er(a,d)170Tm -13.9 170Er(a,tn)170Tm -20.9 168Tm 93.1 b-(0.01) 184.295(2) 18.15(16) 166Er(a,d)168Tm -14.3 e (99.99) 198.251(2) 54.49(16) 167Er(a,t)168Tm -14.5 447.515(3) 23.98(11) 168Er(a,tn)168Tm -22.3 815.989(5) 50.95(16) 170Er(a,t3n)168Tm -35.5 167Tm 9.25 e (100) 207.801(5) 42(8) 164Er(a,p)167Tm -8.3 166Er(a,dn)167Tm -21.2 167Er(a,tn)167Tm -21.3 168Er(a,t2n)167Tm -29.1 170Er(a,t4n)167Tm -42.4 166gTm 7.70 e (100) 184.405(25) 16.2(10) 164Er(a,d)166Tm -14.8 705.333(20) 11.1(7) 166Er(a,tn)166Tm -23.6 778.814(15) 19.1(12) 167Er(a,t2n)166Tm -27.6 785.904(15) 10.0(6) 168Er(a,t3n)166Tm -37.8 1273.540(16) 15.0(9) 2052.36(3) 17.4(11) 165Tm 30.06 e (100) 242.917(7) 35.5(17) 162Er(a,p)165Tm -8.3 297.369(6) 12.7(6) 164Er(a,t)165Tm -15.5 166Er(a,t2n)165Tm -30.7 167Er(a,t3n)165Tm -37.1 168Er(a,t4n)165Tm -44.9

3.2.4 t 8.5–29.0% mQ H t L0.2–27.7%M

L1%M L1%M L5%M L6%M L< 19%ML3%M 2 。 m H

Page 32: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

26

4.

4.1 169Tm

169Yb mQ 169,170,171,172Lu 167,168,170Tm Ht m 2 H V a

mt n t V H mV r H t

b t n 、k H e 4-1V 4-8 t 9 aH

Page 33: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

27

3 M 978 L 3105

2 0 4 4 4 4 3 3 3 .1

6 6 6 6 6 6 6 6 66 6 6 6 6 66 6 6 6 6 6 6 6 66 6 6 6 6 6 6

6 6 6 6 6 6 6 6 66 6 6 6 6 6 66 6 6 6 6 6 6 6 66 6 6 6 6 6 66 6 6 6 6 6 6 6 66 6 6 6 6 6 66 6 6 6 6 6 6 6 66 6 6 6 6 6 66 6 6 6 6 6 6 6 6 6 66 6 6 66 6 6 66 6 6 6

6 6 6 6

Page 34: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

28

4.1.1 169Yb£¢

169Yb�T1/2 = 32.018 Ä�$�Éxf46Ð#ZK¡�±�isomeric state�2�� �èh�a2�v 1�$ 3Gr��v 2�$ 1Gr·���.�ZK¡�± ÔX�/#!�Ó �a o���/��#�*�qT#£¢µØ¤$d½�±�ZK¡�±#礶� ���/�(��ÖÊP�$�Z 169Lu�T1/2 = 34.06 �a��-#eÜ ¬��/�4.1.3.1¥����0�qT�� 4-3�2Þ�/����169Lu #eÜ2��O��qT�ÃᣢµØ¤�individual cross section (ind) �2Â��µØ¤#��!$ 177.21 keV�Ig = 22.28%�#8FB§2Þ���� 4-1 !����� 169Yb #µØ¤2 169Lu #eÜ c(0�¶�礵ؤ�cumulative cross section (cum)��eÜ2��O���ind�l!���

50.7 MeV(�#qT�$�?�:I·2����$�� ����V�#qT$�¦�tk,.+²��¶2�.�TENDL-2017$�vqT�Ì\��U�ÎR���/qT� ���}!��#ÊP!��/ 169Yb#£¢!$ 169Lu#eÜ ²����ß��/�� 1����

� 4-1 169Tm(a,x)169YbÊPµØ¤#qT�¦�tki& TENDL-2017#Ì\

0 200 400 600 800

1000 1200 1400 1600 1800

30 35 40 45 50 55

169Tm(α,x)169Yb

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Mohan Rao 1992TENDL-2017This work (ind) #1This work (ind) #2This work (cum) #1This work (cum) #2

Page 35: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

29

4.1.2 169Yb£¢å 4.1.1¥�j*�µØ¤2w!����£¢å2�4-2!���ª�È!$ SRIM code2Þ��50.7 MeV(�£¢å#N���/ physical yield(Otuka and Sándor Takács, 2015)2�����

� 4-2 169Tm(a,x)169YbÊPµØ¤#�vqT!,/£¢å

0

500

1000

1500

2000

0 10 20 30 40 50 60

Physical Yield of 169YbPh

ysic

al y

ield

(kBq

/µAh

)

Particle energy (MeV)

169Tm+α(ind)169Tm+α(cum)

Page 36: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

30

4.1.3 Ñ£¢Ò#£¢ 169Tm '#4E@3ã�Å�ÊP!����169Yb #­!�WÂ-0�Ñ£¢Ò����

169,170,171,172Lui& 167,168,170Tm �/��0�0#£¢µØ¤2HQ!���

4.1.3.1 169Lu£¢ 4.1.1�gê��º.�169Lu�T1/2 = 34.06 �a�$ 169Yb£¢!�ß Ú^2³£¢Z���/��#��$�Ñ£¢Ò��/ 169Lu�#+##µØ¤!���gê2��

960.62 keV�Ig = 23.4%�#8FB§2Þ������ 169Lu#£¢µØ¤2� 4-3!��� V�#�vqT#?�:I·$�¦�tk�Y"N¸�/qT� �� �?�:I·!��/µØ¤ ¦�tk2200 mb�-500 mb¾À�W/qT� ���TENDL-2017$�©�#�vqT!°��?�:I· »�Õ!K / �V�#�vqT�?�:�#�²¶ Y"N¸�/qT� ���

� 4-3 169Tm(a,4n)169LuÊPµØ¤#qT�¦�tki& TENDL-2017#Ì\

0

200

400

600

800

1000

1200

1400

30 35 40 45 50 55

169Tm(α,4n)169Lu

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Sau 1968Singh 1990Mohan Rao 1992Mohan Rao 1994Patel 1999TENDL-2017This work #1This work #2

Page 37: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

31

4.1.3.2 170Lu£¢ 170Lu�T1/2 = 2.012 Ä�#£¢µØ¤2 1280.25 keV�Ig = 8.18%�#8FB§�-����qT2� 4-4!���èh�a$�v 1�2l! 3ľÀ��/� V�#�vqT$¦�tk�?�:I·$N¸�/ �µØ¤ �,� 400 mb�- 500

mb K /qT� ���TENDL-2017 $�?�:I· �v¶!°�»�6=E9�!�.�µØ¤+¦�tk!°��$²���V�#�v!°��$���qT� ���

� 4-4 169Tm(a,3n)170LuÊPµØ¤#qT�¦�tki& TENDL-2017#Ì\

0

200

400

600

800

1000

1200

1400

1600

25 30 35 40 45 50 55

169Tm(α,3n)170Lu

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Sau 1968Singh 1990Mohan Rao 1992Mohan Rao 1994Patel 1999TENDL-2017This work #1This work #2

Page 38: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

32

4.1.3.3 171Lu£¢ 171gLu�T1/2 = 8.24 Ä�!$Éxf 79Ð#ZK¡�± 171mLu ¬��/��0$�èh�a

3Ä#a!_©!ÔX�/�~-0/�*�d½�±��/ 171gLu#ÔX8FB§ 739.78 keV�Ig = 47.8%�2«¼�/����d½�±�ZK¡�±�-#eÜ �p�0� 171Lu#礣¢µØ¤ Â-0/�qT2� 4-5!��� �W#6=E9�ËJ 28.0 MeV�-50.7 MeV#�*��#£¢ÊP!b��$?�:I·27>��/qT$Â-0 ����V�#�vqT$�¦�tk,.+²��¶2����TENDL-2017$¦�tk 2s(Singh, Agarwal and Rama Rao, 1990; Mohan Rao, Mukherjee and Rao, 1992)�n|$N¸�/ �£¢µØ¤$²��¶2����

� 4-5 169Tm(a,2n)171LuÊPµØ¤#qT�¦�tki& TENDL-2017#Ì\

0

200

400

600

800

1000

1200

15 20 25 30 35 40 45 50 55

169Tm(α,2n)171Lu

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Sau 1968Singh 1990Mohan Rao 1992Mohan Rao 1994Patel 1999TENDL-2017This work #1This work #2

Page 39: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

33

4.1.3.4 172Lu£¢ 172gLu�T1/2 = 6.7 Ä�$�Éxf 3.7Ó#ZK¡�±2������ -��v 1�2l!Û 3Ä#èh�a2·���.��#a!ZK¡�±$d½�±!_©!ÔX���~-0/��#�*�d½�±#8FB§ 1094.66 keV�Ig = 62.5%�2«¼�/����d½�±�ZK¡�±#礣¢µØ¤ ���0/��#qT2� 4-6!��� ¦�tk!,/��?�:$ 20 MeV¨z!¬��/�*�28.0 MeV�- 50.7 MeV2«¼���W#�v�$`«�� ����NÕ��6=E9�æM# #) Â-0��n|$¦�tk�Y"N¸�/ �®�²��¶� ���TENDL-2017$á�� .#6=E9�I·$�vqT�N¸�/ �?�:#6=E9�I·$�v¶,.+»� ���.�?�:I·,.+��6=E9�æM�$µØ¤$�vqT,.+»�¶� ���/�

� 4-6 169Tm(a,n)172LuÊPµØ¤#qT�¦�tki& TENDL-2017#Ì\

0

10

20

30

40

50

60

70

80

0 10 20 30 40 50

169Tm(α,n)172Lu

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Sau 1968Singh 1990Mohan Rao 1992Mohan Rao 1994Patel 1999Kiss 2011Rauscher 2012TENDL-2017This work #1This work #2

Page 40: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

34

4.1.3.5 167Tm£¢ 167Tm�T1/2 = 9.25 Ä�$��Z 167Yb�T1/2 = 17.5 Ó�#Éxf ´��*�èh�a#a!_©!ÔX���/�~/�� ��/��#�*��0-#Z�#�p 礵ؤ�������/�èh�a$�v 1�2l!Û 3Ä�����(��£¢µØ¤#��!�Þ�� 207.8 keV�Ig = 41%�#8FB§$�169Lu#ÔX�#8FB§ 207.727 keV�Ig = 0.390%��� ���/�*�4.1.3.1 ¥�����µØ¤�-eÜÓ2u¤+.��O��µØ¤#��2� ����#qT2� 4-7!��� V�#�vqT$¦�tk�Y"N¸�/qT� ������ -�50.7 MeV(�#qT��/�*�?�:I·2é1!�/��$�� ����TENDL-2017$©¯¿!�vqT�Ì\��U²ÎR���

� 4-7 169Tm(a,x)167TmÊPµØ¤#qT�¦�tki& TENDL-2017#Ì\

0

10

20

30

40

50

25 30 35 40 45 50 55

169Tm(α,x)167Tm

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Singh 1990Mohan Rao 1992TENDL-2017This work #1This work #2

Page 41: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

35

4.1.3.6 168Tm£¢ 168Tm�T1/2 = 93.1 Ä�$Éxf Ì\¿¹��2016Æ 2r!�����à�Å��v#�!£¢�0�Ó _©!$ÔX���-���âå2ÎR�� 1WÙ#�v�-��O���2WÙ#�v�$ 2016Æ�à�Å��v#�âÓ!S� 1WÙ#�âÓ+~ä�/��� .�{� ²�� ���(�*���2µÇ����#�*��#£¢ÊP!b��$�1WÙ#�vqT#)2���µØ¤#��!$�815.99 keV�Ig = 50.95%�#8FB§2�Þ���qT2� 4-8!���

50.7 MeV(�#qT�$?�:I·$y0 ����V�#�vqT$�K /qT2�����2s#¦�tk(Singh, Agarwal and Rama Rao, 1990; Mohan Rao, Mukherjee and Rao, 1992)#a!m§2Ï�qT� ���(��TENDL-2017$�vqT�?�:I·�µØ¤l!©�Ln|2����

� 4-8 169Tm(a,an)168TmÊPµØ¤#qT�¦�tki& TENDL-2017#Ì\

0

20

40

60

80

100

120

15 20 25 30 35 40 45 50 55

169Tm(α,αn)168Tm

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Singh 1990Mohan Rao 1992TENDL-2017This work #1

Page 42: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

36

4.1.3.7 170Tm£¢ 170Tm�T1/2 = 128.6 Ä�$�4.1.3.7 �# 168Tm �ÁÝ!�va]�Ì\���× ¹��

2016 Æ 2 r#�à�Å��v#�âÓ2~ä� �0% - ���#�*{� ²���2WÙ#4E@3ã�Å��v�$��2µÇ���84.25 keV�Ig = 2.48%�#8FB§2Þ������µØ¤2� 4-9!��� �#ÊP�$ EXFORC5ACD!¦�tk ¬����Ö�v �«¼� /�TENDL-

2017$V�#�vqT�Ì\��µØ¤2U�ÎR���/�� 1����

� 4-9 169Tm(a,3He)170TmÊPµØ¤#qT� TENDL-2017#Ì\

0

50

100

150

200

30 35 40 45 50 55

169Tm(α,3He)170Tm

Cro

ss s

ectio

n (m

b)

Energy (MeV)

TENDL-2017This work #1

Page 43: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

37

4.2 natEr'#4E@3ã�Å�ÊP�v

169Yb#­!�Ñ£¢Ò��/ 166Ybi& 165,166,167,168,170,173Tm#£¢µØ¤2[Â����0�0#�vqT2� 4-10�-� 4-17!����¶<�;$Í 10!���

Page 44: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

38

517 6 E T M M 420

8 3 0 .2 .2 4 4 4 4 4 49 9 9 9 9 9 9 99 9 9 9 9 9 9 99 9 9 9 9 9 9 99 9 9 9 9 9 9 99 9 9 9 9 9 9 9 99 9 9 9 9 9 9 9 99 9 9 9 9 9 99 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9

Page 45: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

39

4.2.1 169YbĂĀ 169

Yb(�Ħñė 169gYb�T1/2 = 32.02 ĺ�&i�"�uZÿñė 169m

Yb�T1/2 = 46 ň��ĔÅ�3�� �%�1�uZÿñė( 11 ĺ'ų�Õ~'~&�Ħñė&zċ&ŕr�"�2�o�(�Ħñė$uZÿñė'ŲĄĂĀĚŜĄ6ĸ"3�đĥ&(��Ħñė&��3ŕrÕ';WNĊ 177.21 keV�Ig = 22.28%�6ÉŦ���o�'Ü¢�l6Ĉº���) TENDL-2017$�&ý 4-10&Ö��

Király1'F�B$ TENDL-2017(o�'�l$ĵť'ô3ō6��35 MeVŊ�&I�=Yĝ 6Ô ���4�4ĚŜĄ'Ę���Z%3�l$%���ĕ'Ĉº��'F�B(�.Ę��.Z%3�

ý 4-10 nat

Er(a,x)169

YbńfĚŜĄ'�l$Ĉº���) TENDL-2017'Ņv

0

100

200

300

400

500

600

0 10 20 30 40 50

natEr(α,x)169Yb

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Homma 1980Sonzogni 1992Archenti 1985Kiraly 2008TENDL2017This work

Page 46: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

40

4.2.2 169Yb'ĂĀů 169

Yb'ĂĀů6 4.2.1Ć#�-�ĂĀĚŜĄ6£&Èè���čÑĿ( SRIM code6Ŧ"�physical yield6 48.9 MeV+#�È���ý 4-11&(Ĉº��#�3 Király1'F�B$'Ņv6Ö��o�'�-�ĂĀĚŜĄ(�ý 4.2.1#.¡"��0& Király 1'ĂĀĚŜĄ02.í��-�ý 4-11'0& Király 1'ĂĀů'¡Ą.202.í��l$%���

ý 4-11 nat

Er(a,x)169

YbńfĚŜĄ'Ü¢�l&03ĂĀů

0

200

400

600

800

1000

10 15 20 25 30 35 40 45 50

Physical Yield of 169Yb

Inte

gral

yie

ld (k

Bq/µ

Ah)

Energy (MeV)

Kiraly 2008This work

Page 47: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

41

4.2.3 ŎĂĀŐ'ĂĀ �'ńf&�"�169

Yb'ĕ&ŎĂĀŐ#�3 166Yb�) 165,166,167,168,170,173

Tm'ĂĀĚŜĄ6ĸ���'�l6Xg&Ö��

4.2.3.1 165

TmĂĀ

165Tm�T1/2 = 30.06 Õ~�'ĂĀĚŜĄ(�242.92 keV�Ig = 35.5%�';WNĊ6đĥ�3

�$#Èè���2.2Õ~'ų�Õ~'~&�ùu#�3 165Yb�T1/2 = 9.9 ő�(zċ&ŕr

�"�2�¿qÈè��ĂĀĚŜĄ(�165Yb$ 165

Tm'ŲĄě#�3�ý 4-12&�l6Ĉº���) TENDL-2017 $Ņv��.'6Ö��Király 1'F�B(o�'�l$^Ğ�3��Homma1'F�B(o�02.í�ě6$���TENDL-2017( 38 MeVXï'Ű]#Ü¢�l$Z%3ô3ō6,���

ý 4-12 nat

Er(a,x)165

TmńfĚŜĄ'�l$Ĉº���) TENDL-2017'Ņv

0

10

20

30

40

50

0 10 20 30 40 50

natEr(α,x)165Tm

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Homma 1980Kiraly 2008TENDL2017This work

Page 48: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

42

4.2.3.2 166

TmĂĀ

166Tm(Ń¥�7.70 Õ~'�Ħñė'ĕ&�Ń¥�340 OSň'uZÿñė�ĔÅ�3�

uZÿñė( 11 Õ~'ų�Õ~6ĝ�¿q'đĥ#(�zċ&ŕr�"3�+��ùu#�3 166

Yb�T1/2 = 56.7 Õ~�(�166Tm 02.Ń¥��ġ�-�đĥÕ&(ŕrĭ

Ġ'ùu&03e��ÀÅ��ñė#�3��'e�( 4.2.3.7Ć�ý 4-18�&"Èè�43ĚŜĄ 1¡Ą.2�Á�`���Ħñė 166g

Tm'ŕrÕ';WNĊ 778.81 keV�Ig =

19.1%� 1Èè��ĂĀĚŜĄ6ý 4-13&Ö��

�'ńf( EXFORR9KRS&Ĉº���ĔÅ�% ���-�TENDL-2017$'Ņv',6ý&Ö���TENDL-2017(o�'Ü¢F�B02.ě�í���ô3ō.[�l$%���

ý 4-13 nat

Er(a,x)166

TmńfĚŜĄ'�l$ TENDL-2017'Ņv

0

20

40

60

80

100

120

140

30 35 40 45 50

natEr(α,x)166Tm

Cro

ss s

ectio

n (m

b)

Energy (MeV)

TENDL2017This work

Page 49: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

43

4.2.3.3 167

TmĂĀ

167Tm�T1/2 = 9.25 ĺ�'ĂĀĚŜĄ6 707.80 keV�Ig = 42%�';WNĊ&0�"Èè���

đĥ( 11ĺ'ų�Õ~6ĝ"ÜÐ���ùu#�3 167Yb �T1/2 = 17.5 ő�(�'ų�Õ

~'~&zċ&ŕr�"3�-�167Tm'ģąĂĀ�4�ő&i�" 167

Yb 1'�Ť�½��4�ŲĄĂĀĚŜĄ�Èè�4"3�¿qđĥ&ÉŦ��;WNĊ'�Į� 19%

'¬Á6Ô�"3�-�¬Á�Ę��%�"3�Ü¢�l$Ĉº���) TENDL-2017

$'Ņv6ý 4-14&Ö��

o�'Ü¢�l(Ĉº��2�'~&�Ċ6Ň��TENDL-2017(35 MeV+#(Ü¢F�B$Ů^Ğ6Ö����35MeVX»(Ü¢F�B02.í�ě6$���

ý 4-14 nat

Er(a,x)167

TmńfĚŜĄ'�l$Ĉº���) TENDL-2017'Ņv

0

100

200

300

400

500

600

700

0 10 20 30 40 50

natEr(α,x)167Tm

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Homma 1980Kiraly 2008TENDL2017This work

Page 50: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

44

4.2.3.4 168

TmĂĀ

168Tm�T1/2 = 93.1 ĺ�'ĂĀĚŜĄ(�247ĺ'ų�Õ~''��815.99 keV�Ig = 50.95%�

';WNĊ6đĥ�"Èè����l6Ĉº���) TENDL-2017$�&ý 4-15&Ö��

o�'Ü¢F�B( Sonzogni1$0�^Ğ��TENDL-2017(�±6æ�"3.''�ě(Ü¢ě6gq3�l$%���Homma1'Ü¢F�B(ô3ō�o�/Sonzogni1'Ü¢F�B�) TENDL-2017$ %2Z%3�l$%�"3�

ý 4-15 nat

Er(a,x)168

TmńfĚŜĄ'�l$Ĉº���) TENDL-2017'Ņv

0

5

10

15

20

25

30

35

10 15 20 25 30 35 40 45 50

natEr(α,x)168Tm

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Homma 1980Sonzogni 1992TENDL2017This work

Page 51: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

45

4.2.3.5 170

TmĂĀ

170Tm�T1/2 = 128.6 ĺ�'ĂĀĚŜĄ(�247 ĺ'ų�Õ~6ĝ�ª& 84.25 keV�Ig =

2.48%�ŕr;WNĊ6đĥ�3�$#ĸ14��ý 4-16&�'�l$ TENDL-2017'Ņv6Ö��

�'ńf'Ü¢F�B( ENFORF�BM�A&ĔÅ�%�TENDL-2017(Ü¢F�B02.Ĥě6$���

ý 4-16 nat

Er(a,x)170

TmńfĚŜĄ'�l$ TENDL-2017'Ņv

0

5

10

15

20

20 25 30 35 40 45 50

natEr(α,x)170Tm

Cro

ss s

ectio

n (m

b)

Energy (MeV)

TENDL2017This work

Page 52: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

46

4.2.3.6 173

TmĂĀ

173Tm�T1/2 = 8.24 Õ~�(�2.2Õ~'ų�Õ~''� 398.9 keV�Ig = 87.9%�';WNĊ6

đĥ�3�$#ý 4-17&Ö�ĚŜĄ6ĸ��

Ĉº��(o�'Ü¢ě02.Ę���I�=Yĝ(^Ğ���TENDL-2017(Ü¢F�B02.í�ě6$���

ý 4-17 nat

Er(a,x)173

TmńfĚŜĄ'�l$Ĉº���) TENDL-2017'Ņv

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0 10 20 30 40 50

natEr(α,x)173Tm

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Kiraly 2008TENDL2017This work

Page 53: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

47

4.2.3.7 166

YbĂĀ

166Yb�T1/2 = 56.7 Õ~�(�82.29 keV�Ig = 15.552%�'ŕrÕ';WNĊ6đĥ�3�$#

ĚŜĄ6ĸ��ų�Õ~6 11 ĺĝ"đĥ6ÜÐ���o�'Ü¢�l$Ĉº���)TENDL-2017'Ņv6ý 4-18&Ö��

Ĉº�� 2 �$.�o�'Ü¢F�B02.í�ě6á3�$�5 ���^ŗ�TENDL-2017(Ü¢ě02.Ę�ě6Ö�"3�

ý 4-18 nat

Er(a,x)166

YbńfĚŜĄ'�l$Ĉº���) TENDL-2017'Ņv

0

100

200

300

400

500

600

15 20 25 30 35 40 45 50

natEr(α,x)166Yb

Cro

ss s

ectio

n (m

b)

Energy (MeV)

Sonzogni 1992Archenti 1985TENDL2017This work

Page 54: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

48

5. ¹Æ

�4+#º%�"�� 169Tm *'çŧÍĻÝ�)8TJ7ŬÍĻÝ�nat

Er *'8TJ7ŬÍĻÝÜ¢�l6Ŧ"ĂĀů�thick target yield�6Èè��ńf6Ņv�3�

ĂĀů'^ã#�3 physical yield(Otuka and Takács, 2015)6Èè���l'Ņv6ý 5-1&Ö��

ý 5-1 physical yield'Ņv

natEr*'8TJ7ŬÍĻÝńf'�l(�20 MeV 1|/ &Đi��50 MeV#ş 800

kBq/µAh&%3�^ŗ�169Tm*'8TJ7ŬÍĻÝńf#(�40 MeV 1��&Đi��

50 MeV#( 1600 kBq/µAh&iję�3�+��169Tm*'çŧÍĻÝńf(��1&Ĥ:

HT<�#�3ş 10 MeV 1��&Đi��24 MeV#ş 5000 kBq/µAh$%3�ǹ$�"Tárkáyni1&03 169

Tm*'ŧÍĻÝńf(Tárkányi et al., 2012)'ě$Ņv�3$�13 MeV+#çŧÍ$ĵť'�±$%3.''�02¼:HT<�#(ĂĀů�î%�%3�$�5 ���

�'�l 1�169Tm*'çŧÍĻÝńf�Ĥ:HT<�#Ä.Ė�' 169

Yb6ĂĀ#�3�$�5 3�0�"�mīŬÍĻÝńf6Ŧ� 169

YbĂĀ'Ġ#(�169Tm*'ç

ŧÍĻÝ�Ä.°ũ�Ů$¹�143�

0

1000

2000

3000

4000

5000

6000

0 10 20 30 40 50 60

Physical Yield of 169Yb

Phys

ical

yie

ld (k

Bq/µ

Ah)

Particle energy (MeV)

169Tm+d169Tm+α(ind)169Tm+α(cum)natEr+α169Tm+p(Tarkayni)

Page 55: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

49

6. ďx�0)�ŷ

\ŭŦŖÝÿuã'®Ŕ'^ #�3 169Yb 'ĂĀ& "�mīŬÍĻÝńfÜ¢'

F�B�ʼnĒ�"3��'�-�169YbĂĀ&��3mīŬÍĻÝńfÜ¢6�IJĨ&Ü

Ð�"����4+#&�169Tm *'çŧÍĻÝ�8TJ7ŬÍĻÝ�) nat

Er *'8TJ7ŬÍĻÝÜ¢6Ũhw��ë AVF?9=UGUW&"ÜÐ���ŖÝhĄĎŁŘ�);WNĊő¯Ř&"ĂĀĚŜĄ6Èè���

µ&�41'Ü¢F�B6£&ĂĀů'^ã#�3 physical yield 6Èè��¿+#ÜÐ�"�� 3 'Ü¢$ 169

Tm*'ŧÍĻÝńfÜ¢'Ĉº��6Ņv���ĂĀů'Ņv 1�169

Tm*'çŧÍĻÝńf�02Ĥ:HT<�#Ä.Ė�' 169Yb6ĂĀ#�3�

$�5 ���ĂĀů'}ĩ 1¦Õĩ#(�mīŬÍĻÝńf&03 169Yb ĂĀ#(�

169Tm*'çŧÍĻÝ�Ä.°ũ�Ů$�ŷ!���

Page 56: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

50

ÞØ

Ś¸'Úņ&��2���űĢ�Ė�'ŗ�*�'ð6ß2"÷�«ŵø�ï�+��àļÎĶ�_#�3½ĉā´�ä&(�åËnħ 1' 5Ľ~&Ĭ2��'�Č 1û-ŗċ"&�"þ�'«ÎĶ�)«ì§6���+���ŎÎĶ�_�gŢÊ�ä�œĪţ^é�ä&(ŚŷŒ6òÂ�"���+���+��bð²¯D�PS�C��íöš�Í���ű_6Ì-$�3Ũhw��ë'tť�) Takács Sándorïă��_�Ditrói

Ferencïă��_�Szűcs Zoltánïă��_Ì-$�3ATOMKI>T�L'tť&(�Ŵ��þđĥÜ¢'�Č 1«ÎĶ�)Ü¢&��3«ì§6���+���ŏį Ū\kĘw'a�ģľì�(�\ŭ�'ĜÙ�%Ò&þ�'\wĨ%ĜÙ�őŞ'¦ñı6��"���+���õĬ©A=�Tï�LU>RP'�_�)ĵ�Ă&�"(�ŒŨŝ5�ĕőŞ'ŗ�$'­ū'�p6Ģ��ê-"×őę'â&03V�=@QEL'cd/×ő'��6ĕőŞ&3ü&±�"ćś�3�ç%�p$%2+���ݳĘw'·łå^ŶĹļì�&� 4+�"(�¤ÍuőŞ'�ČĜÙ6ú&ğ�3ì�&%�"���+���řsķĘw¤ÍuŨŷ��Û'tť&(�Ś��Û&wĂ�Ò^ü#���¾ 1wĂĵË'­ū��ŷ'ð 1¨Ū�%0óŀ2���+�����"�Ś��Û¶Ā_'tť(Ò&ĵőŞ'wĂĵË'�ŷ�#�3�p6Ť�"���2+���Ī&�Ò&��&æÓ�3�p6Ť�"�4�Ō�ŸĴÜ�Ăy6Ï�"�4�ŋ�Š�6Ì-$�3jē&{Þø�ï�+��

Page 57: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

51

`ŦŒ�

Archenti, A. et al. (1985) ‘(α,xn) Reactions on Natural Erbium’, Radiochimica Acta, 38, pp. 65–68. doi:

10.1524/ract.1985.38.2.65.

Birattari, C. et al. (1973) ‘Not to be reproduced by photoprint or microfilm without written permission from

the publisher PRE-EQUILIBRIUM PROCESSES IN (p,n) REACTIONS’, ~ Nuclear Physics, 201, pp. 579–592.

Available at: https://ac-els-cdn-com.afit.idm.oclc.org/0375947473903229/1-s2.0-0375947473903229-

main.pdf?_tid=17219995-a6a6-4044-b2de-

c1832396eda8&acdnat=1555419793_deb6a68d3761fe7aa7f4ed9133c989d4.

Chu, S. Y. F., Ekström, L. P. and Firestone, R. B. (1999) The Lund/LBNL Nuclear Data Search. Available at:

http://nucleardata.nuclear.lu.se/toi/.

DeLand, F. H. et al. (1971) ‘Cisternography with 169Yb-DTPA’, The Journal of Nuclear Medicine, 12, pp. 683–

689.

Hermanne, A. et al. (2009) ‘Excitation functions for production of medically relevant radioisotopes in

deuteron irradiations of Pr and Tm targets’, Nuclear Instruments and Methods in Physics Research, Section

B: Beam Interactions with Materials and Atoms, 267(5), pp. 727–736. doi: 10.1016/j.nimb.2008.12.017.

Hermanne, A. et al. (2016) ‘Extension of excitation functions up to 50 MeV for activation products in

deuteron irradiations of Pr and Tm targets’, Nuclear Instruments and Methods in Physics Research, Section

B: Beam Interactions with Materials and Atoms, 383(September), pp. 81–88. doi:

10.1016/j.nimb.2016.06.010.

Hermanne, A. et al. (2018) ‘Reference Cross Sections for Charged-particle Monitor Reactions’, Nuclear Data

Sheets, 148, pp. 338–382. doi: 10.1016/j.nds.2018.02.009.

Homma, Y. et al. (1980) ‘Cyclotron production of 167

Tm from natural erbium and natural holmium’, Applied

Radiation and Isotopes, 31, pp. 505–508. doi: 10.1016/0020-708X(80)90314-2.

IAEA - Nuclear Data Section (no date) Nuclear Data services. Available at: https://www-nds.iaea.org/.

International Atomic Energy Agency (2009) LiveChart of Nuclides. Available at: https://www-

nds.iaea.org/livechart/.

Király, B. et al. (2008) ‘Excitation functions of alpha-induced nuclear reactions on natural erbium’, Nuclear

Instruments and Methods in Physics Research Section B, 266, pp. 549–554. doi:

10.1016/j.nimb.2007.12.067.

Kiss, G. G. et al. (2011) ‘Activation method combined with characteristic X-ray counting: A possibility to

measure (α,γ) cross sections on heavy p-nuclei’, Nuclear Physics A. Elsevier B.V., 867(1), pp. 52–65. doi:

10.1016/j.nuclphysa.2011.07.003.

Kiss, G. G. et al. (2015) ‘Measurement of (α,n) reaction cross sections of erbium isotopes for testing

astrophysical rate predictions’, Journal of Physics G: Nuclear and Particle Physics. IOP Publishing, 42, p.

055103. doi: 10.1088/0954-3899/42/5/055103.

Koning, A. J. et al. (2019) ‘TENDL: Complete Nuclear Data Library for Innovative Nuclear Science and

Technology’, Nuclear Data Sheets. Elsevier Inc., 155, pp. 1–55. doi: 10.1016/j.nds.2019.01.002.

Leyden, D. E. and Murthy, R. S. S. (1988) ‘Diffuse reflectance Fourier transform IR spectroscopy’, Trends in

Analytical Chemistry. Elsevier B.V., 7(5), pp. 164–169. doi: 10.1016/j.physletb.2010.11.052.

Page 58: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

52

Lymperopoulou, G. et al. (2006) ‘A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the

breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities’, Medical Physics,

33(12), pp. 4583–4589. doi: 10.1118/1.2392408.

Mohan Rao, A. V. and Chintalapudi, S. N. (1994) ‘Pre-Equilibrium Decay Process in Alpha Particle Induced

Reactions on Thulium and Tantalum’, Journal of the Physical Society of Japan, 63(1), pp. 84–91. doi:

10.1143/JPSJ.63.84.

Mohan Rao, A. V., Mukherjee, S. and Rao, J. R. (1992) ‘Investigation of alpha particle induced reactions on

thulium’, Pramana, 38(3), pp. 279–290. doi: 10.1007/BF02875374.

National Nuclear Data Center (2017) Nuclear structure and decay data on-line library, Nudat 2.7. Available

at: http://www.nndc.bnl.gov/nudat2/.

Van Noorden, R. (2013) ‘Radioisotopes: The medical testing crisis’, Nature, 504(7479), pp. 202–204. doi:

10.1038/504202a.

Otuka, N. et al. (2014) ‘Towards a More complete and accurate experimental nuclear reaction data library

(EXFOR): International collaboration between nuclear reaction data centres (NRDC)’, Nuclear Data Sheets,

120, pp. 272–276. doi: 10.1016/j.nds.2014.07.065.

Otuka, N. and Takács, Sándor (2015) ‘Definitions of radioisotope thick target yields’, Radiochimica Acta,

103(1), pp. 1–6. doi: 10.1515/ract-2013-2234.

Otuka, N. and Takács, Sandor (2015) ‘Definitions of radioisotope thick target yields’, Radiochimica Acta,

103(1), pp. 1–6. doi: 10.1515/ract-2013-2234.

Pritychenko, B. and Sonzogni, A. (2003) Q-value Calculator (QCalc). Available at:

http://www.nndc.bnl.gov/qcalc/.

Rauscher, T. et al. (2012) ‘Astrophysical analysis of the measurement of (α,γ) and (α,n) cross sections of

169Tm’, Physical Review C - Nuclear Physics, 86(1). doi: 10.1103/PhysRevC.86.015804.

Saito, M. et al. (2017) ‘Production cross sections of 169Yb and Tm isotopes in deuteron-induced reactions on

169Tm’, Applied Radiation and Isotopes, 125, pp. 23–26. doi: 10.1016/j.apradiso.2017.04.010.

Sau, J., Demeyer, A. and Chéry, R. (1968) ‘ÉTUDE EXPIÉRIMENTALE ET ANALYSE DES FONCTIONS

D’EXCITATION 165Ho(α, xn) ET 169Tm(α, xn)’, Nuclear Physics A, 121, pp. 131–144.

Singh, N. L., Agarwal, S. and Rama Rao, J. (1990) ‘Comparative Study of Pre-Equilibrium Models and

Mechanism of Alpha Particle Induced Reactions’, Journal of the Physical Society of Japan, 59(11), pp. 3916–

3924. doi: 10.1143/JPSJ.59.3916.

Sonnabend, K. et al. (2011) ‘Activation experiments for p-process nucleosynthesis’, Journal of Physics:

Conference Series, 312(SECTION 4). doi: 10.1088/1742-6596/312/4/042007.

Sonzogni, A. A. et al. (1992) ‘Alpha-induced reactions on natural erbium’, Journal of Radioanalytical and

Nuclear Chemistry, Letters, 165, pp. 295–303. doi: 10.1007/BF02169776.

Spahn, I. et al. (2005) ‘Cross-section measurement of the 169Tm(p,n) reaction for the production of the

therapeutic radionuclide 169Yb and comparison with its reactor-based generation’, Applied Radiation and

Isotopes, 63(2), pp. 235–239. doi: 10.1016/j.apradiso.2005.03.006.

Tárkányi, F. et al. (2007) ‘Activation cross sections of the 169Tm(d,2n) reaction for production of the

therapeutic radionuclide 169Yb’, Applied Radiation and Isotopes, 65(6), pp. 663–668. doi:

10.1016/j.apradiso.2007.01.008.

Page 59: 荷電粒子入射反応における医療用放射性核種169Yb …...to produce medical radionuclide 169Yb) 2020 3 K Ì ÿ Ñ × Á ò H (Moemi HANADA) U Y 、. ... 0 50 100 150

53

Tárkányi, F. et al. (2012) ‘Activation cross-sections of proton induced nuclear reactions on thulium in the 20-

45MeV energy range’, Applied Radiation and Isotopes, 70(1), pp. 309–314. doi:

10.1016/j.apradiso.2011.08.020.

U.S. Department of Energy (no date) NIDC: National Isotope Development Center. Available at:

https://www.isotopes.gov/.

Watanabe, T. et al. (2014) ‘Beam energy and longitudinal beam profile measurement system at the RIBF’, in

Proceedings of the 5th International Particle Accelerator Conference (IPAC 2014), pp. 3566–3568.

Ziegler, J. F., Biersack, J. P. and Ziegler, M. D. (2008) SRIM: the Stopping and Range of Ions in Matter.

Available at: http://www.srim.org.